View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson

Earnings beat on adj. EBIT in Q4

Underlying earnings better than expected. 4.2% organic sales growth in Q4. Near-term uncertainty persists, but long-term potential unchanged.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson

Low growth but margin improvements expected

Q4'23 results due 6 February. Instrument sales to drive growth in Q4e. 27-33% below historical NTM P/E and NTM EV/EBITDA.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson

Return to positive growth in Q3

4.3% organic sales growth. Improved cash flow generation. Near-term uncertainty, but long-term potential unchanged.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Gonzalo Artiach

Uncertain geopolitical situation

Geopolitical situation compromises Boule's performance. 5-part system sales pushed to '25 due to the need for improvements. Macro situation & GM pressure brings ABGSCe down for '23-'25.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Gonzalo Castanon
ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Erik Cassel
  • Gonzalo Artiach

A good start to the year

Price adjustments and better supply chain lift gross margin. Leaving behind a turbulent 2022, it seems that Boule is back on track.

ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Erik Cassel
  • Gonzalo Castanon
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch